首页> 外文期刊>The Journal of Antimicrobial Chemotherapy >embCAB sequence variation among ethambutol-resistant Mycobacterium tuberculosis isolates without embB306 mutation.
【24h】

embCAB sequence variation among ethambutol-resistant Mycobacterium tuberculosis isolates without embB306 mutation.

机译:在无embB306突变的耐乙胺丁醇的结核分枝杆菌菌株中embCAB序列变异。

获取原文
获取原文并翻译 | 示例
获取外文期刊封面目录资料

摘要

OBJECTIVES: Mechanisms of resistance to ethambutol in Mycobacterium tuberculosis remain inadequately described. Although there is mounting evidence that mutations of codon 306 in embB play a key role, a significant number of phenotypically ethambutol-resistant strains do not carry mutations in this codon. Here, other mutations in the embCAB operon are suggested to be involved in resistance development. METHODS: The entire embCAB operon ( approximately 10 kb) was analysed in 34 phenotypically ethambutol-resistant M. tuberculosis strains without mutations in embB306 and in 12 ethambutol-susceptible strains. Furthermore, 106 control strains were investigated for the presence of particular mutations only. RESULTS: Overall, 18 non-synonymous mutations in 15 distinct codons of the embCAB operon were identified in ethambutol-resistant strains but not in ethambutol-susceptible isolates. The majority occurred in the embB gene (10 distinct codons), in a 570 bp region also encompassing embB306. Mutations in embC and embA were found rarely and in most cases in combination with polymorphisms in embB. One synonymous mutation (embA 228 bp) and two non-synonymous mutations (embCVal981Leu and embCArg738Gln) were found in ethambutol-susceptible strains as well as resistant strains and were confirmed to represent phylogenetic markers for strains of the Beijing, Haarlem and Delhi/CAS genotypes, respectively. CONCLUSIONS: Besides mutations in embB306, mutations in embB406 and embB497 were confirmed as hot spots for genomic variation in ethambutol-resistant clinical isolates. Of all resistant strains 70.6% carry a mutation in a relatively short region in embB, which therefore represents a promising target for inclusion in molecular assays for rapid detection of ethambutol resistance.
机译:目的:对结核分枝杆菌对乙胺丁醇的抗性机制仍未充分描述。尽管越来越多的证据表明embB中306位密码子的突变起关键作用,但大量表型抗乙胺丁醇的菌株在此密码子中不携带突变。在这里,embCAB操纵子的其他突变被认为与耐药性的发展有关。方法:在34个表型上具有乙胺丁醇抗性的结核分枝杆菌菌株中分析了整个embCAB操纵子(约10 kb),在embB306和12个对乙胺丁醇敏感的菌株中没有突变。此外,仅针对特定突变的存在对106个对照菌株进行了研究。结果:总体上,在抗乙胺丁醇的菌株中鉴定出embCAB操纵子的15个不同密码子中的18个非同义突变,但在对乙胺丁醇敏感的菌株中未鉴定到。大多数发生在embB基因(10个不同的密码子)中,也包含embB306的570 bp区域。 embC和embA的突变很少见,大多数情况下与embB的多态性结合。在乙胺丁醇易感菌株和抗性菌株中发现了一个同义突变(embA 228 bp)和两个非同义突变(embCVal981Leu和embCArg738Gln),并被证实代表了北京,哈勒姆和德里/ CAS基因型的系统发育标记。 , 分别。结论:除embB306中的突变外,embB406和embB497中的突变被证实是耐乙胺丁醇临床分离株中基因组变异的热点。在所有耐药菌株中,有70.6%的突变在embB的较短区域携带,因此代表了有望用于快速检测乙胺丁醇耐药性的分子分析中的目标。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号